GFAP and periventricular leukomalacia: Stewart et al. [6] demonstrated that levels of circulating GFAP on days 1-4 of life are significantly elevated in preterm neonates that later on developed PVL and that even among neonates with IVH, GFAP could identify which ones were at higher risk for the later development of PVL.